Responding to the Rising Incidence of Hepatocellular Carcinoma With Targeted Therapy

Por Choo, Su-Pin, Venook, Alan P.
Publicado em 2008

Prognostic and Predictive Markers in Stage II Colon Cancer: Is There a Role for Gene Expression Profiling?

Por Kelley, Robin K., Venook, Alan P.
Publicado em 2011

Biomarker Use in Colorectal Cancer Therapy

Por Kelley, Robin K., Wang, Grace, Venook, Alan P.
Publicado em 2011

Section III: Treatment of Advanced Gastrointestinal Cancers

Por Hochster, Howard S., O’Reilly, Eileen M., Ajani, Jaffer A., Venook, Alan P.
Publicado em 2007

Section I: Essentials of Ensuring Excellence in Cancer Care

Por Goldberg, Richard M., Marshall, John L., Kachnic, Lisa A., Venook, Alan P.
Publicado em 2007

Personalized Medicine and Oncology Practice Guidelines: A Case Study of Contemporary Biomarkers in Colorectal Cancer

Por Kelley, Robin K., Van Bebber, Stephanie L., Phillips, Kathryn A., Venook, Alan P.
Publicado em 2011

Nonoperative therapies for combined modality treatment of hepatocellular cancer: expert consensus statement

Por Schwarz, Roderich E, Abou-Alfa, Ghassan K, Geschwind, Jeffrey F, Krishnan, Sunil, Salem, Riad, Venook, Alan P
Publicado em 2010

Section IV: Significance of Recent Study Results and Future Research Directions in Gastrointestinal Oncology

Por Goldberg, Richard M., Marshall, John L., Ajani, Jaffer A., Philip, Philip A., O’Reilly, Eileen M., Venook, Alan P.
Publicado em 2007

A Phase II Study of Long-Acting Octreotide in Patients With Advanced Hepatocellular Carcinoma and CLIP Score of 3 or Higher

Por Shah, Usman, O’Neil, Bert, Allen, Jill, Goldberg, Richard M., Bernard, Steven, Moore, Dominic, Venook, Alan P., Morse, Michael M.
Publicado em 2009

When Progressive Disease Does Not Mean Treatment Failure: Reconsidering the Criteria for Progression

Por Oxnard, Geoffrey R., Morris, Michael J., Hodi, F. Stephen, Baker, Laurence H., Kris, Mark G., Venook, Alan P., Schwartz, Lawrence H.
Publicado em 2012

25-Hydroxyvitamin D Levels and Survival in Advanced Pancreatic Cancer: Findings From CALGB 80303 (Alliance)

Por Van Loon, Katherine, Owzar, Kouros, Jiang, Chen, Kindler, Hedy L., Mulcahy, Mary F., Niedzwiecki, Donna, O’Reilly, Eileen M., Fuchs, Charles, Innocenti, Federico, Venook, Alan P.
Publicado em 2014

Prognostic and Predictive Blood-Based Biomarkers in Patients with Advanced Pancreatic Cancer: Results from CALGB80303 (Alliance)

Por Nixon, Andrew B., Pang, Herbert, Starr, Mark D., Friedman, Paula N., Bertagnolli, Monica M., Kindler, Hedy L., Goldberg, Richard M., Venook, Alan P., Hurwitz, Herbert I.
Publicado no Clin Cancer Res (2013)

Gene Expression Markers of Efficacy and Resistance to Cetuximab Treatment in Metastatic Colorectal Cancer: Results from CALGB 80203 (Alliance)

Por Cushman, Stephanie M., Jiang, Chen, Hatch, Ace J., Shterev, Ivo, Sibley, Alexander B., Niedzwiecki, Donna, Venook, Alan P., Owzar, Kouros, Hurwitz, Herbert I., Nixon, Andrew B.
Publicado no Clin Cancer Res (2014)

Identification of Potential Prognostic Biomarkers in Patients with Untreated, Advanced Pancreatic Cancer from a Phase III Trial (CALGB 80303)

Por Roberts, Andrew S., Campa, Michael J., Gottlin, Elizabeth B., Jiang, Chen, Owzar, Kouros, Kindler, Hedy L., Venook, Alan P., Goldberg, Richard M., O’Reilly, Eileen M., Patz, Edward F.
Publicado em 2011

Bone metastases and skeletal-related events from neuroendocrine tumors

Por Van Loon, Katherine, Zhang, Li, Keiser, Jennifer, Carrasco, Cendy, Glass, Katherine, Ramirez, Maria-Teresa, Bobiak, Sarah, Nakakura, Eric K, Venook, Alan P, Shah, Manisha H, Bergsland, Emily K
Publicado no Endocr Connect (2015)

Development of a Research Agenda for the Management of Metastatic Colorectal Cancer: Proceedings from a Multidisciplinary Research Consensus Panel

Por d’Othée, Bertrand Janne, Sofocleous, Constantinos T., Hanna, Nader, Lewandowski, Robert J., Soulen, Michael C., Vauthey, Jean-Nicolas, Cohen, Steven J., Venook, Alan P., Johnson, Matthew S., Kennedy, Andrew S., Murthy, Ravi, Geschwind, Jean-Francois, Kee, Stephen T.
Publicado no J Vasc Interv Radiol (2012)

Blood‐based markers of efficacy and resistance to cetuximab treatment in metastatic colorectal cancer: results from CALGB 80203 (Alliance)

Por Hatch, Ace J., Sibley, Alexander B., Starr, Mark D., Brady, J. Chris, Jiang, Chen, Jia, Jingquan, Bowers, Daniel L., Pang, Herbert, Owzar, Kouros, Niedzwiecki, Donna, Innocenti, Federico, Venook, Alan P., Hurwitz, Herbert I., Nixon, Andrew B.
Publicado no Cancer Med (2016)

Biologic Determinants of Tumor Recurrence in Stage II Colon Cancer: Validation Study of the 12-Gene Recurrence Score in Cancer and Leukemia Group B (CALGB) 9581

Por Venook, Alan P., Niedzwiecki, Donna, Lopatin, Margarita, Ye, Xing, Lee, Mark, Friedman, Paula N., Frankel, Wendy, Clark-Langone, Kim, Millward, Carl, Shak, Steven, Goldberg, Richard M., Mahmoud, Najjia N., Warren, Robert S., Schilsky, Richard L., Bertagnolli, Monica M.
Publicado em 2013

Circulating tumor cells in hepatocellular carcinoma: a pilot study of detection, enumeration, and next-generation sequencing in cases and controls

Por Kelley, Robin K, Magbanua, Mark Jesus M, Butler, Timothy M, Collisson, Eric A, Hwang, Jimmy, Sidiropoulos, Nikoletta, Evason, Kimberley, McWhirter, Ryan M, Hameed, Bilal, Wayne, Elizabeth M, Yao, Francis Y, Venook, Alan P, Park, John W
Publicado no BMC Cancer (2015)

Phase I Trial of Sorafenib Following Liver Transplantation in Patients with High-Risk Hepatocellular Carcinoma

Por Siegel, Abby B., El-Khoueiry, Anthony B., Finn, Richard S., Guthrie, Katherine A., Goyal, Abhishek, Venook, Alan P., Blanke, Charles D., Verna, Elizabeth C., Dove, Lorna, Emond, Jean, Kato, Tomoaki, Samstein, Benjamin, Busuttil, Ronald, Remotti, Helen, Coffey, Amy, Brown Jr, Robert S.
Publicado no Liver Cancer (2015)